Stoke Therapeutics Inc Long-term Investment Intensity
Stoke Therapeutics Inc long-term investment intensity. Stoke Therapeutics Inc (STOK) has a Long-term Investment Intensity of 15.6% as of June 2026. Long-term investments of $61.50 Million represent 15.6% of total assets of $393.97 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See STOK current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Stoke Therapeutics Inc (2024–2025)
Long-term investment intensity of Stoke Therapeutics Inc from 2024 to 2025. This chart shows how Stoke Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the intensity stands at 15.6%, reflecting long-term investments of $61.50 Million against total assets of $393.97 Million USD. See operational self-sufficiency of Stoke Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
Stoke Therapeutics Inc Long-term Investment Intensity by Year (2024–2025)
Stoke Therapeutics Inc long-term investment intensity by year from 2024 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Stoke Therapeutics Inc from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Stoke Therapeutics Inc asset portfolio.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 25.4% | $106.26 Million | $418.43 Million | ▲ +14.4 pp |
| 2024 | 11.0% | $29.82 Million | $271.56 Million | — |